A well-studied immune checkpoint is cytotoxic T lymphocyte-associated antigen-4 (CTLA-4), which primarily regulates T-cell activity in the early tumor microenvironment and has a strong correlation with T cells in all cancer types [127,128]. Here, CTLA4 is linked to cancer.